Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Royalty
Welcome,
Profile
Billing
Logout
27 Products
153 Diseases
27 Products
222 Trials
17695 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
15
30
45
60
75
90
105
120
135
150
Tysabri
(natalizumab) / Biogen, Royalty
Tazverik
(tazemetostat) / Ipsen
Adlyxin
(lixisenatide) / Sanofi
Idhifa
(enasidenib) / BMS, Servier
Spinraza
(nusinersen) / Biogen
Trelegy Ellipta
(fluticasone furoate/umeclidinium bromide/vilanterol) / GSK, Innoviva, Theravance Biopharma
Cobenfy
(xanomeline/trospium) / BMS
Evrysdi
(risdiplam) / Roche
Niktimvo
(axatilimab-csfr) / Syndax Pharma, Incyte
pelacarsen
(AKCEA-APO(a)-LRx) / Novartis
Qinprezo
(vosaroxin) / Denovo
omecamtiv mecarbil
(AMG 423) / Amgen, Servier
Skytrofa
(lonapegsomatropin-tcgd) / Ascendis
MK-8189
/ Merck (MSD)
Orladeyo
(berotralstat) / BioCryst
Adstiladrin
(nadofaragene firadenovec-vncg) / Ferring
ampreloxetine
(TD-9855) / Theravance Biopharma
Oxlumo
(lumasiran) / Alnylam
frexalimab
(SAR441344) / Sanofi
litifilimab
(BIIB059) / Biogen
daraxonrasib
(RMC-6236) / Revolution Medicines
Yorvipath
(palopegteriparatide) / Ascendis
olpasiran
(AMG 890) / Amgen
Natroba
(spinosad) / Royalty
deucrictibant immediate-release capsule
(PHVS416) / Pharvaris
olanzapine LAI
(TEV-'749) / Teva, MedinCell
deucrictibant extended-release tablet
(PHVS719) / Pharvaris
trontinemab
(RG6102) / Roche
